SUBSCRIBE: eNewsletter
The latest developments in both new and novel approaches to treating sleep disorders. ©designer491/shutterstock
Recommendations from the International Society of Bipolar Disorders Task Force on Chronobiology and Chronotherapy and the Society for Light Treatment and Biologic Rhythms.
Blue spectrum light can worsen two systems that are already fragile in people with mood disorders: sleep and circadian rhythms. Fortunately, there are simple solutions to correct this problem.
Concerned about daylight savings time? This patient handout offers tips for getting a good night's sleep.
Sleep-related problems are among the most disabling consequences of TBI, with multiple influences: impairment of neuronal plasticity, metabolomic alterations, loss of vascular homeostasis, and disruption of the blood-brain barrier. The authors take a close look.
Circadian components are profound in depressive disorders, such seasonal affective disorder. This article introduces a course to be given at this year’s APA Meeting in Toronto, on melatonin and light treatment.
What's new in sleep medicine? The latest developments in both new and novel approaches to treating sleep disorders.
What is sleep normally and what are the primary factors that regulate sleep? Understanding that the primary factors that regulate the sleep wake cycle are homeostatic and circadian will help clinicians assess sleep problems in patients.
Melatonin has a role in psychiatric illness and the treatment of circadian rhythm sleep disorders, insomnia, and comorbid depressive disorders.
Sleep changes associated with psychotropic drugs are common enough to justify routinely obtaining a baseline sleep diary before beginning treatment, even when the initial screening for sleep disorders indicates that no further investigation is needed.
This discussion focuses on approaches to improve medication adherence, particularly in reference to helping adolescents remain on recommended psychopharmacological regimens when transitioning from acute to long-term maintenance.
We've noticed that you're using an ad blocker
Our content is brought to you free of charge because of the support of our advertisers. To continue enjoying our content, please turn off your ad blocker.
